GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: MRL-367 is a selective, small molecule antagonist of RORγt, an isoform of RORγ (RAR related orphan receptor C), with antiinflammatory potential [1].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References | 
| Rheumatoid arthritis | Disease Ontology: 
                                                                        DOID:7148 OMIM: 180300 | Experimental compound with predicted application in RA. | |
| Inflammatory bowel disease | Disease Ontology: 
                                                                        DOID:0050589 OMIM: 266600 | Experimental compound with predicted application in inflammatory bowel disease. | |
| Psoriatic arthritis | Disease Ontology: 
                                                                        DOID:9008 | Experimental compound with predicted application in PsA. | |
| Ankylosing spondylitis | Disease Ontology: 
                                                                        DOID:7147 | Experimental compound with predicted application in ankylosing spondylitis. | |